首页> 外文期刊>American journal of therapeutics >Primary Evan Syndrome With Disseminated Intravascular Coagulation Suggests Progressive Immune Dysregulation and Early Immunosuppressive Intervention is Key to Improving Outcomes
【24h】

Primary Evan Syndrome With Disseminated Intravascular Coagulation Suggests Progressive Immune Dysregulation and Early Immunosuppressive Intervention is Key to Improving Outcomes

机译:弥散性血管内凝血的原发性伊文综合征表明,进行性免疫失调和早期免疫抑制干预是改善预后的关键

获取原文
获取原文并翻译 | 示例
           

摘要

Evan syndrome (ES) is a rare hematological disorder that involves 2 or more immune cytopenias. It usually includes autoimmune hemolytic anemia and autoimmune thrombocytopenia. Although occasionally associated with immune neutropenia, its association with disseminated intravascular coagulation (DIC) is rare. And, early diagnosis with appropriate intervention is important because mortality from ES is known to be greater than that of isolated immune hemolytic anemia and probably worse in the presence of DIC. Considering that the presence of DIC can make the diagnosis of ES challenging, a strong clinical suspicion is important as early initiation of therapy is critical to reducing the morbidity and mortality associated with this syndrome. We report a case of ES complicated by DIC.
机译:伊文综合症(ES)是一种罕见的血液病,涉及2个或更多的免疫性血细胞减少症。它通常包括自身免疫性溶血性贫血和自身免疫性血小板减少症。尽管偶尔与免疫性中性粒细胞减少有关,但其与弥散性血管内凝血(DIC)的相关性很少。而且,通过适当的干预进行早期诊断非常重要,因为已知ES的死亡率要高于孤立的免疫溶血性贫血,而在DIC的情况下可能更糟。考虑到DIC的存在会使ES的诊断具有挑战性,因此强烈的临床怀疑非常重要,因为尽早开始治疗对于降低与该综合征相关的发病率和死亡率至关重要。我们报告了一例由DIC导致的ES病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号